Your session is about to expire
← Back to Search
Oral Riboflavin for Refractive Errors
Study Summary
This trial will test whether riboflavin and time outdoors can prevent near-sightedness in children.
- Refractive Errors
- Myopia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: 400 mg Riboflavin (oral)
- Group 2: 0 mg Riboflavin (oral)
- Group 3: 200 mg Riboflavin (oral)
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Frequently Asked Questions
What medical concerns can Oral Riboflavin ameliorate?
"Oral Riboflavin is traditionally employed to address dietary or nutritional issues, and can be used therapeutically for vitamin deficiency syndromes, joint aches and pains, or as a supplement."
What is the aggregate participant count of this research endeavor?
"Affirmative. Per the information hosted on clinicaltrials.gov, this medical research is actively recruiting participants. It was first posted in October 2018 and last revised April 2021, seeking 100 volunteers across one trial site."
Has the FDA sanctioned Oral Riboflavin as a viable medical treatment?
"Our team has rated the safety of Oral Riboflavin at a 2. This is based on it being in Phase 2, where clinical data supports its safety but no studies have validated efficacy yet."
Has Oral Riboflavin been evaluated in prior research endeavors?
"Presently, there are 17 investigations into the effects of Oral Riboflavin with 8 research projects in Phase 3. Most studies for this drug take place in San Francisco but 44 other medical sites across the globe have also activated trials."
Are additional test subjects being accepted for this research endeavor?
"Yes, the information hosted by clinicaltrials.gov validates that this study is proactively enrolling participants. This trial was first submitted on October 10th 2018 and has since been revised to reflect new data as of April 16 2021. The research team needs 100 individuals from a single medical centre for participation in the experiment."
Is the recruitment for this trial restricted to individuals of a certain age?
"According to the outlined criteria for this medical trial, only participants aged 6-12 are able to take part."
Is it feasible for me to join this research endeavor?
"To be eligible to partake in this research, potential participants must have refractive errors and fall between the age range of 6-12 years. A maximum of 100 patients are being accepted into this clinical trial."
Share this study with friends
Copy Link
Messenger